Studies

EEN in complicated CD

Adalimumab in stricturing CD

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a Randomized Controlled Trial

Adalimumab +/- azathioprine tight control vs clincal management in CD

Efficacy and Safety of Oral Budesonide in Patients with Active Crohn’s Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study

ADA vs AZA in postop recurrence in CD

Newborn exposed to antiTNF safety

Infliximab increase dose in CD

IFX originator to CT-P13 in IBD

anti-MAdCAM antibody PF-00547659 in CD